COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients (PROTECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02036554
Recruitment Status : Unknown
Verified September 2014 by ChulWoo Yang, Seoul St. Mary's Hospital.
Recruitment status was:  Recruiting
First Posted : January 15, 2014
Last Update Posted : September 25, 2014
Information provided by (Responsible Party):
ChulWoo Yang, Seoul St. Mary's Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : December 2015